The Real Cost of GLP-1 Therapy in India: A Doctor's Complete 2026 Price Guide
By Dr. Neha Shah, Bariatric & Metabolic Surgeon, Co-Founder & Clinical Lead, The Good Weight
Key Takeaways
- Generic semaglutide in India costs from ₹1,290/month at the starting dose, rising to ₹1,300–4,200/month at maintenance doses.
- Branded Ozempic and Wegovy cost from ~₹5,660/month after Novo Nordisk's April 2026 price cuts (up to 48% off Wegovy, 36% off Ozempic).
- Mounjaro (tirzepatide) is the most expensive option, running ₹13,125–27,500/month depending on dose, since it remains under patent with no generic yet.
- Semaglutide's Indian patent expired on 20 March 2026, triggering 40+ DCGI-approved generic brands.
- Total monthly cost should also include labs, physician consults, and nutrition support — not just the medicine strip price.
- No IRDAI-regulated insurance in India currently covers GLP-1 medication for the obesity indication.
Almost every Member who walks into our Chennai or Bengaluru centres asking about GLP-1 therapy starts with the same question, and it isn't about side effects or efficacy. It's: "Doctor, how much is this actually going to cost me every month?"
It's a fair question, and in 2026 the honest answer is "it depends enormously on which molecule, which brand, and which pathway you choose" — because this market has changed more in the last twelve months than in the previous five years combined. Two events reshaped GLP-1 pricing in India this year: semaglutide's Indian patent expired on 20 March 2026, opening the door to 40+ generic brands, and Novo Nordisk responded on 1 April 2026 by cutting its own Ozempic and Wegovy prices by up to 36–48%.
As a clinician who prescribes and titrates these medications daily, I want to walk you through exactly what you'll pay — medicine, consults, labs, and the costs nobody mentions on Instagram — so you can budget for this properly before you start.
Quick Answer: What Does GLP-1 Therapy Cost in India in 2026?
| Medication | Molecule | Monthly Cost (Starting Dose) | Monthly Cost (Maintenance Dose) |
|---|---|---|---|
| Generic Semaglutide (vials) | Semaglutide | ₹1,290–1,300 | ₹1,300–4,200 |
| Generic Semaglutide (pens) | Semaglutide | ₹1,800–4,500 | ₹4,000–6,000 |
| Ozempic (branded) | Semaglutide | ~₹5,660 | ~₹9,000 (1 mg) |
| Wegovy (branded) | Semaglutide | ~₹5,660 | ~₹16,400 (2.4 mg) |
| Mounjaro (branded) | Tirzepatide | ₹13,125–14,000 (2.5 mg) | ₹22,000–27,500 (10–15 mg) |
Prices are typical Indian retail MRP as of mid-2026 and vary by city, pharmacy chain and exact dose. Always confirm current pricing with your prescribing doctor or pharmacy at the time of purchase.
Why Prices Just Fell: The Two Events That Changed Everything
1. The Semaglutide Patent Expired (20 March 2026)
Semaglutide — the molecule in Ozempic and Wegovy — lost patent protection in India this March. Within weeks, more than 40 DCGI-approved generic brands entered the market from major Indian manufacturers including Natco, Sun Pharma, Dr. Reddy's, Cipla, Zydus, Alkem and Glenmark. Vial-based generics now start from as little as ₹1,290 a month, and pen-format generics from roughly ₹1,800–4,500.
2. Novo Nordisk Cut Its Own Prices (1 April 2026)
Facing genuine price competition for the first time, Novo Nordisk cut Ozempic prices by up to 36% and Wegovy prices by up to 48%. The starting 0.25 mg dose of both now costs roughly ₹5,660 a month — a fraction of what it did in late 2025.
3. Tirzepatide (Mounjaro) Remains Untouched
Tirzepatide is still under patent in India, with generics not expected before 2027–28. As the only dual GIP/GLP-1 agonist available here, and India's top-selling drug by value since October 2025, its pricing hasn't moved — it remains the most expensive option on the table, running from roughly ₹13,000 at the starting dose to ₹25,000–27,500 at higher maintenance doses.
Branded vs Generic: What Are You Actually Paying For?
This is the question I get asked most, and I want to be clinically precise about it rather than diplomatic. Generic semaglutide contains the same active molecule as Ozempic and Wegovy. What you're paying extra for with the branded pen is:
- Manufacturing and quality assurance track record from an internationally audited facility.
- Device engineering — branded auto-injector pens are generally easier to dose accurately than drawing from a vial with a syringe.
- A longer real-world safety and outcomes dataset, including cardiovascular and kidney outcome trials that some generics haven't yet replicated in India.
What matters clinically is that whichever option you choose, it should be a DCGI-approved brand, sourced from a licensed pharmacy, and prescribed and titrated by a doctor — never self-purchased or self-dosed. At The Good Weight, our clinical team reviews the manufacturer, batch quality, and cold-chain handling before we recommend any specific brand to a Member, because with an injectable prescription drug, the ₹1,000 you save by cutting corners on sourcing is not worth the risk.
The Hidden Costs Nobody Mentions
The medicine strip price is only part of the real monthly outlay. Here's what a properly run GLP-1 programme should also budget for:
- Baseline and follow-up labs — thyroid panel, HbA1c/fasting glucose, kidney and liver function, lipid profile. Typically ₹2,000–4,000 at baseline, repeated every 3–6 months.
- Physician consultation and titration support — dose changes should be doctor-guided, not self-managed off a YouTube video. Budget ₹1,000–2,500 per review consult, or a bundled monthly programme fee.
- Body composition monitoring — a BCA (body composition analysis) scan tracks how much of your weight loss is fat versus muscle, which matters enormously on GLP-1 (see our companion article on muscle loss). Most clinics offer this at ₹500–1,500 per scan.
- Protein and nutrition support — appetite suppression makes it genuinely hard to hit protein targets through food alone; many Members add a protein supplement or a structured food kit, typically ₹1,500–2,500/month.
- Cold-chain storage — GLP-1 pens need 2–8°C refrigeration; factor this into travel and storage planning, especially in Chennai's climate.
Six-Month Cost Reality Check: What You'll Actually Spend
Because these medications are titrated — you start low and increase the dose gradually over several months — your early months cost meaningfully less than your maintenance months. A rough six-month picture for generic semaglutide, including consults and labs, typically lands between ₹25,000 and ₹45,000 total; branded Wegovy or Ozempic across the same period runs ₹55,000 to ₹90,000+; and Mounjaro, given both its higher starting price and its faster escalation to more expensive doses, commonly totals ₹1–1.5 lakh over six months.
These are wide ranges deliberately — your actual number depends on your starting BMI, how quickly you tolerate dose increases, and which brand you and your doctor choose together.
Is GLP-1 Therapy Covered by Insurance in India?
As things stand in 2026, no IRDAI-regulated health insurance policy in India covers GLP-1 medication when prescribed purely for the obesity indication. If you have type 2 diabetes and the medication is prescribed for glycaemic control, some policies may partially reimburse consultation and diagnostic costs — but the medicine itself is almost always an out-of-pocket expense. Ask your insurer directly and get it in writing before you assume coverage.
A Doctor's Honest Take on Value, Not Just Price
I'd be doing you a disservice if I only talked about rupees. The real cost comparison isn't generic-versus-branded — it's supervised-versus-unsupervised. I have seen Members who bought the cheapest available vial online, self-dosed without medical guidance, and ended up with severe nausea, dehydration, or a dose that was simply wrong for their body — costing them far more in emergency consults and lost time than they saved on the medicine.
A properly run programme accounts for your total cost of care: the medicine, the monitoring, the nutrition support to protect your muscle mass, and a plan for what happens when you eventually come off the drug (which we cover in detail in our article on weight regain after GLP-1). That's a very different number — and a very different outcome — from just the cheapest strip price you can find.
Frequently Asked Questions About GLP-1 Cost in India
How much does GLP-1 therapy cost per month in India in 2026?
GLP-1 therapy in India in 2026 costs between ₹1,290/month for generic semaglutide and ₹27,500/month for the highest-dose branded Mounjaro (tirzepatide). Most Members budget ₹4,000–16,000/month depending on the molecule, brand, and dose stage.
Is generic semaglutide as effective as Ozempic or Wegovy?
Generic semaglutide contains the same active molecule as Ozempic and Wegovy. Efficacy depends on the molecule and dose, not the brand name — but sourcing quality, device accuracy, and doctor supervision matter, which is why choosing a DCGI-approved brand through a licensed pharmacy is essential.
Why did GLP-1 prices drop in India in 2026?
Two events reduced prices: semaglutide's Indian patent expired on 20 March 2026, allowing 40+ generic brands to launch, and Novo Nordisk cut its own Ozempic and Wegovy prices by up to 36–48% on 1 April 2026 to compete.
Does insurance cover GLP-1 weight loss medication in India?
No IRDAI-regulated health insurance policy in India currently covers GLP-1 medication prescribed for the obesity indication. Some policies may partially cover consultation and diagnostic costs if the medication is prescribed for type 2 diabetes management.
Is Mounjaro or generic semaglutide the better choice on a budget?
For most Members prioritising cost, DCGI-approved generic semaglutide offers the lowest starting price. Mounjaro (tirzepatide) tends to produce somewhat greater average weight loss in trials but costs significantly more, since it remains patent-protected in India with no generic currently available. The right choice depends on your clinical profile and should be made with your doctor.
Not sure which GLP-1 option — or budget — is right for your body?
Book a one-on-one consultation with Dr. Neha Shah and The Good Weight's clinical team. We'll assess your metabolic profile, walk you through the real cost of every option, and build a plan that fits your body and your budget — not just the cheapest pen on the shelf.
This article is for informational purposes and does not replace individualised medical advice. GLP-1 medications are Schedule H prescription drugs in India and should only be started, dosed, or stopped under the supervision of a registered physician. Prices are indicative as of mid-2026 and subject to change; confirm current pricing with your pharmacy at the time of purchase.
About the Author: Dr. Neha Shah is a bariatric and metabolic surgeon and Co-Founder & Clinical Lead of The Good Weight, a doctor-led metabolic health and weight loss programme with centres in Chennai and Bengaluru.